Skip to main content
PMC home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1999 Feb;79(5-6):718–723. doi: 10.1038/sj.bjc.6690115

Analysis of the 10q23 chromosomal region and the PTEN gene in human sporadic breast carcinoma

H E Feilotter 1,#, V Coulon 2,#, J L McVeigh 2,#, A H Boag 2, F Dorion-Bonnet 2, B Duboué 2, W C W Latham1 2, C Eng 3, L M Mulligan 1, M Longy 2
PMCID: PMC2362663  PMID: 10070859

Abstract

We examined a panel of sporadic breast carcinomas for loss of heterozygosity (LOH) in a 10-cM interval on chromosome 10 known to encompass the PTEN gene. We detected allele loss in 27 of 70 breast tumour DNAs. Fifteen of these showed loss limited to a subregion of the area studied. The most commonly deleted region was flanked by D10S215 and D10S541 and encompasses the PTEN locus. We used a combination of denaturing gradient gel electrophoresis and single-strand conformation polymorphism analyses to investigate the presence of PTEN mutations in tumours with LOH in this region. We did not detect mutations of PTEN in any of these tumours. Our data show that, in sporadic breast carcinoma, loss of heterozygosity of the PTEN locus is frequent, but mutation of PTEN is not. These results are consistent with loss of another unidentified tumour suppressor in this region in sporadic breast carcinoma. © 1999 Cancer Research Campaign

Keywords: breast carcinoma, chromosome 10q, Cowden disease, PTEN

Full Text

The Full Text of this article is available as a PDF (153.4 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Albarosa R., Colombo B. M., Roz L., Magnani I., Pollo B., Cirenei N., Giani C., Conti A. M., DiDonato S., Finocchiaro G. Deletion mapping of gliomas suggest the presence of two small regions for candidate tumor-suppressor genes in a 17-cM interval on chromosome 10q. Am J Hum Genet. 1996 Jun;58(6):1260–1267. [PMC free article] [PubMed] [Google Scholar]
  2. Bevilacqua G., Sobel M. E., Liotta L. A., Steeg P. S. Association of low nm23 RNA levels in human primary infiltrating ductal breast carcinomas with lymph node involvement and other histopathological indicators of high metastatic potential. Cancer Res. 1989 Sep 15;49(18):5185–5190. [PubMed] [Google Scholar]
  3. Bièche I., Lidereau R. Genetic alterations in breast cancer. Genes Chromosomes Cancer. 1995 Dec;14(4):227–251. doi: 10.1002/gcc.2870140402. [DOI] [PubMed] [Google Scholar]
  4. Boström J., Cobbers J. M., Wolter M., Tabatabai G., Weber R. G., Lichter P., Collins V. P., Reifenberger G. Mutation of the PTEN (MMAC1) tumor suppressor gene in a subset of glioblastomas but not in meningiomas with loss of chromosome arm 10q. Cancer Res. 1998 Jan 1;58(1):29–33. [PubMed] [Google Scholar]
  5. Brownstein M. H., Wolf M., Bikowski J. B. Cowden's disease: a cutaneous marker of breast cancer. Cancer. 1978 Jun;41(6):2393–2398. doi: 10.1002/1097-0142(197806)41:6<2393::aid-cncr2820410644>3.0.co;2-k. [DOI] [PubMed] [Google Scholar]
  6. Cairns P., Okami K., Halachmi S., Halachmi N., Esteller M., Herman J. G., Jen J., Isaacs W. B., Bova G. S., Sidransky D. Frequent inactivation of PTEN/MMAC1 in primary prostate cancer. Cancer Res. 1997 Nov 15;57(22):4997–5000. [PubMed] [Google Scholar]
  7. Chen J., Lindblom P., Lindblom A. A study of the PTEN/MMAC1 gene in 136 breast cancer families. Hum Genet. 1998 Jan;102(1):124–125. [PubMed] [Google Scholar]
  8. Chumakov I. M., Rigault P., Le Gall I., Bellanné-Chantelot C., Billault A., Guillou S., Soularue P., Guasconi G., Poullier E., Gros I. A YAC contig map of the human genome. Nature. 1995 Sep 28;377(6547 Suppl):175–297. doi: 10.1038/377175a0. [DOI] [PubMed] [Google Scholar]
  9. Devilee P., Cornelisse C. J. Somatic genetic changes in human breast cancer. Biochim Biophys Acta. 1994 Dec 30;1198(2-3):113–130. doi: 10.1016/0304-419x(94)90009-4. [DOI] [PubMed] [Google Scholar]
  10. Dorion-Bonnet F., Mautalen S., Hostein I., Longy M. Allelic imbalance study of 16q in human primary breast carcinomas using microsatellite markers. Genes Chromosomes Cancer. 1995 Nov;14(3):171–181. doi: 10.1002/gcc.2870140304. [DOI] [PubMed] [Google Scholar]
  11. Feilotter H. E., Nagai M. A., Boag A. H., Eng C., Mulligan L. M. Analysis of PTEN and the 10q23 region in primary prostate carcinomas. Oncogene. 1998 Apr 2;16(13):1743–1748. doi: 10.1038/sj.onc.1200205. [DOI] [PubMed] [Google Scholar]
  12. FitzGerald M. G., Marsh D. J., Wahrer D., Bell D., Caron S., Shannon K. E., Ishioka C., Isselbacher K. J., Garber J. E., Eng C. Germline mutations in PTEN are an infrequent cause of genetic predisposition to breast cancer. Oncogene. 1998 Aug 13;17(6):727–731. doi: 10.1038/sj.onc.1201984. [DOI] [PubMed] [Google Scholar]
  13. Fujii H., Szumel R., Marsh C., Zhou W., Gabrielson E. Genetic progression, histological grade, and allelic loss in ductal carcinoma in situ of the breast. Cancer Res. 1996 Nov 15;56(22):5260–5265. [PubMed] [Google Scholar]
  14. Gray I. C., Fallowfield J., Ford S., Nobile C., Volpi E. V., Spurr N. K. An integrated physical and genetic map spanning chromosome band 10q24. Genomics. 1997 Jul 1;43(1):85–88. doi: 10.1006/geno.1997.4809. [DOI] [PubMed] [Google Scholar]
  15. Gray I. C., Phillips S. M., Lee S. J., Neoptolemos J. P., Weissenbach J., Spurr N. K. Loss of the chromosomal region 10q23-25 in prostate cancer. Cancer Res. 1995 Nov 1;55(21):4800–4803. [PubMed] [Google Scholar]
  16. Guldberg P., thor Straten P., Birck A., Ahrenkiel V., Kirkin A. F., Zeuthen J. Disruption of the MMAC1/PTEN gene by deletion or mutation is a frequent event in malignant melanoma. Cancer Res. 1997 Sep 1;57(17):3660–3663. [PubMed] [Google Scholar]
  17. Gyapay G., Morissette J., Vignal A., Dib C., Fizames C., Millasseau P., Marc S., Bernardi G., Lathrop M., Weissenbach J. The 1993-94 Généthon human genetic linkage map. Nat Genet. 1994 Jun;7(2 Spec No):246–339. doi: 10.1038/ng0694supp-246. [DOI] [PubMed] [Google Scholar]
  18. Herbst R. A., Weiss J., Ehnis A., Cavenee W. K., Arden K. C. Loss of heterozygosity for 10q22-10qter in malignant melanoma progression. Cancer Res. 1994 Jun 15;54(12):3111–3114. [PubMed] [Google Scholar]
  19. Ittmann M. Allelic loss on chromosome 10 in prostate adenocarcinoma. Cancer Res. 1996 May 1;56(9):2143–2147. [PubMed] [Google Scholar]
  20. Kagan J., Liu J., Stein J. D., Wagner S. S., Babkowski R., Grossman B. H., Katz R. L. Cluster of allele losses within a 2.5 cM region of chromosome 10 in high-grade invasive bladder cancer. Oncogene. 1998 Feb 19;16(7):909–913. doi: 10.1038/sj.onc.1201606. [DOI] [PubMed] [Google Scholar]
  21. Karlbom A. E., James C. D., Boethius J., Cavenee W. K., Collins V. P., Nordenskjöld M., Larsson C. Loss of heterozygosity in malignant gliomas involves at least three distinct regions on chromosome 10. Hum Genet. 1993 Sep;92(2):169–174. doi: 10.1007/BF00219686. [DOI] [PubMed] [Google Scholar]
  22. Kelsey J. L. A review of the epidemiology of human breast cancer. Epidemiol Rev. 1979;1:74–109. doi: 10.1093/oxfordjournals.epirev.a036215. [DOI] [PubMed] [Google Scholar]
  23. Kong D., Suzuki A., Zou T. T., Sakurada A., Kemp L. W., Wakatsuki S., Yokoyama T., Yamakawa H., Furukawa T., Sato M. PTEN1 is frequently mutated in primary endometrial carcinomas. Nat Genet. 1997 Oct;17(2):143–144. doi: 10.1038/ng1097-143. [DOI] [PubMed] [Google Scholar]
  24. Li J., Yen C., Liaw D., Podsypanina K., Bose S., Wang S. I., Puc J., Miliaresis C., Rodgers L., McCombie R. PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer. Science. 1997 Mar 28;275(5308):1943–1947. doi: 10.1126/science.275.5308.1943. [DOI] [PubMed] [Google Scholar]
  25. Liaw D., Marsh D. J., Li J., Dahia P. L., Wang S. I., Zheng Z., Bose S., Call K. M., Tsou H. C., Peacocke M. Germline mutations of the PTEN gene in Cowden disease, an inherited breast and thyroid cancer syndrome. Nat Genet. 1997 May;16(1):64–67. doi: 10.1038/ng0597-64. [DOI] [PubMed] [Google Scholar]
  26. Lynch E. D., Ostermeyer E. A., Lee M. K., Arena J. F., Ji H., Dann J., Swisshelm K., Suchard D., MacLeod P. M., Kvinnsland S. Inherited mutations in PTEN that are associated with breast cancer, cowden disease, and juvenile polyposis. Am J Hum Genet. 1997 Dec;61(6):1254–1260. doi: 10.1086/301639. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Marsh D. J., Coulon V., Lunetta K. L., Rocca-Serra P., Dahia P. L., Zheng Z., Liaw D., Caron S., Duboué B., Lin A. Y. Mutation spectrum and genotype-phenotype analyses in Cowden disease and Bannayan-Zonana syndrome, two hamartoma syndromes with germline PTEN mutation. Hum Mol Genet. 1998 Mar;7(3):507–515. doi: 10.1093/hmg/7.3.507. [DOI] [PubMed] [Google Scholar]
  28. Marsh D. J., Dahia P. L., Coulon V., Zheng Z., Dorion-Bonnet F., Call K. M., Little R., Lin A. Y., Eeles R. A., Goldstein A. M. Allelic imbalance, including deletion of PTEN/MMACI, at the Cowden disease locus on 10q22-23, in hamartomas from patients with Cowden syndrome and germline PTEN mutation. Genes Chromosomes Cancer. 1998 Jan;21(1):61–69. doi: 10.1002/(sici)1098-2264(199801)21:1<61::aid-gcc8>3.0.co;2-6. [DOI] [PubMed] [Google Scholar]
  29. Marsh D. J., Zheng Z., Zedenius J., Kremer H., Padberg G. W., Larsson C., Longy M., Eng C. Differential loss of heterozygosity in the region of the Cowden locus within 10q22-23 in follicular thyroid adenomas and carcinomas. Cancer Res. 1997 Feb 1;57(3):500–503. [PubMed] [Google Scholar]
  30. Morita R., Saito S., Ishikawa J., Ogawa O., Yoshida O., Yamakawa K., Nakamura Y. Common regions of deletion on chromosomes 5q, 6q, and 10q in renal cell carcinoma. Cancer Res. 1991 Nov 1;51(21):5817–5820. [PubMed] [Google Scholar]
  31. Moschonas N. K., Spurr N. K., Mao J. Report of the first international workshop on human chromosome 10 mapping 1995. Cytogenet Cell Genet. 1996;72(2-3):100–112. [PubMed] [Google Scholar]
  32. Myers M. P., Stolarov J. P., Eng C., Li J., Wang S. I., Wigler M. H., Parsons R., Tonks N. K. P-TEN, the tumor suppressor from human chromosome 10q23, is a dual-specificity phosphatase. Proc Natl Acad Sci U S A. 1997 Aug 19;94(17):9052–9057. doi: 10.1073/pnas.94.17.9052. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Nagai M. A., Medeiros A. C., Brentani M. M., Brentani R. R., Marques L. A., Mazoyer S., Mulligan L. M. Five distinct deleted regions on chromosome 17 defining different subsets of human primary breast tumors. Oncology. 1995 Nov-Dec;52(6):448–453. doi: 10.1159/000227509. [DOI] [PubMed] [Google Scholar]
  34. Nagai M. A., Yamamoto L., Salaorni S., Pacheco M. M., Brentani M. M., Barbosa E. M., Brentani R. R., Mazoyer S., Smith S. A., Ponder B. A. Detailed deletion mapping of chromosome segment 17q12-21 in sporadic breast tumours. Genes Chromosomes Cancer. 1994 Sep;11(1):58–62. doi: 10.1002/gcc.2870110109. [DOI] [PubMed] [Google Scholar]
  35. Nelen M. R., Padberg G. W., Peeters E. A., Lin A. Y., van den Helm B., Frants R. R., Coulon V., Goldstein A. M., van Reen M. M., Easton D. F. Localization of the gene for Cowden disease to chromosome 10q22-23. Nat Genet. 1996 May;13(1):114–116. doi: 10.1038/ng0596-114. [DOI] [PubMed] [Google Scholar]
  36. Nelen M. R., van Staveren W. C., Peeters E. A., Hassel M. B., Gorlin R. J., Hamm H., Lindboe C. F., Fryns J. P., Sijmons R. H., Woods D. G. Germline mutations in the PTEN/MMAC1 gene in patients with Cowden disease. Hum Mol Genet. 1997 Aug;6(8):1383–1387. doi: 10.1093/hmg/6.8.1383. [DOI] [PubMed] [Google Scholar]
  37. Parmiter A. H., Balaban G., Clark W. H., Jr, Nowell P. C. Possible involvement of the chromosome region 10q24----q26 in early stages of melanocytic neoplasia. Cancer Genet Cytogenet. 1988 Feb;30(2):313–317. doi: 10.1016/0165-4608(88)90200-2. [DOI] [PubMed] [Google Scholar]
  38. Peiffer S. L., Herzog T. J., Tribune D. J., Mutch D. G., Gersell D. J., Goodfellow P. J. Allelic loss of sequences from the long arm of chromosome 10 and replication errors in endometrial cancers. Cancer Res. 1995 May 1;55(9):1922–1926. [PubMed] [Google Scholar]
  39. Pershouse M. A., Stubblefield E., Hadi A., Killary A. M., Yung W. K., Steck P. A. Analysis of the functional role of chromosome 10 loss in human glioblastomas. Cancer Res. 1993 Oct 15;53(20):5043–5050. [PubMed] [Google Scholar]
  40. Rasheed B. K., McLendon R. E., Friedman H. S., Friedman A. H., Fuchs H. E., Bigner D. D., Bigner S. H. Chromosome 10 deletion mapping in human gliomas: a common deletion region in 10q25. Oncogene. 1995 Jun 1;10(11):2243–2246. [PubMed] [Google Scholar]
  41. Rasheed B. K., Stenzel T. T., McLendon R. E., Parsons R., Friedman A. H., Friedman H. S., Bigner D. D., Bigner S. H. PTEN gene mutations are seen in high-grade but not in low-grade gliomas. Cancer Res. 1997 Oct 1;57(19):4187–4190. [PubMed] [Google Scholar]
  42. Rhei E., Kang L., Bogomolniy F., Federici M. G., Borgen P. I., Boyd J. Mutation analysis of the putative tumor suppressor gene PTEN/MMAC1 in primary breast carcinomas. Cancer Res. 1997 Sep 1;57(17):3657–3659. [PubMed] [Google Scholar]
  43. Risinger J. I., Hayes A. K., Berchuck A., Barrett J. C. PTEN/MMAC1 mutations in endometrial cancers. Cancer Res. 1997 Nov 1;57(21):4736–4738. [PubMed] [Google Scholar]
  44. Sato T., Tanigami A., Yamakawa K., Akiyama F., Kasumi F., Sakamoto G., Nakamura Y. Allelotype of breast cancer: cumulative allele losses promote tumor progression in primary breast cancer. Cancer Res. 1990 Nov 15;50(22):7184–7189. [PubMed] [Google Scholar]
  45. Simon D., Heyner S., Satyaswaroop P. G., Farber M., Noumoff J. S. Is chromosome 10 a primary chromosomal abnormality in endometrial adenocarcinoma? Cancer Genet Cytogenet. 1990 Jul 15;47(2):155–162. doi: 10.1016/0165-4608(90)90025-6. [DOI] [PubMed] [Google Scholar]
  46. Singh B., Ittmann M. M., Krolewski J. J. Sporadic breast cancers exhibit loss of heterozygosity on chromosome segment 10q23 close to the Cowden disease locus. Genes Chromosomes Cancer. 1998 Feb;21(2):166–171. [PubMed] [Google Scholar]
  47. Smith S. A., Ponder B. A. Predisposing genes in breast and ovarian cancer: an overview. Tumori. 1993 Oct 31;79(5):291–296. doi: 10.1177/030089169307900501. [DOI] [PubMed] [Google Scholar]
  48. Starink T. M., van der Veen J. P., Arwert F., de Waal L. P., de Lange G. G., Gille J. J., Eriksson A. W. The Cowden syndrome: a clinical and genetic study in 21 patients. Clin Genet. 1986 Mar;29(3):222–233. doi: 10.1111/j.1399-0004.1986.tb00816.x. [DOI] [PubMed] [Google Scholar]
  49. Steck P. A., Pershouse M. A., Jasser S. A., Yung W. K., Lin H., Ligon A. H., Langford L. A., Baumgard M. L., Hattier T., Davis T. Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers. Nat Genet. 1997 Apr;15(4):356–362. doi: 10.1038/ng0497-356. [DOI] [PubMed] [Google Scholar]
  50. Stoppa-Lyonnet D., Laurent-Puig P., Essioux L., Pagès S., Ithier G., Ligot L., Fourquet A., Salmon R. J., Clough K. B., Pouillart P. BRCA1 sequence variations in 160 individuals referred to a breast/ovarian family cancer clinic. Institut Curie Breast Cancer Group. Am J Hum Genet. 1997 May;60(5):1021–1030. [PMC free article] [PubMed] [Google Scholar]
  51. Stratton M. R. Recent advances in understanding of genetic susceptibility to breast cancer. Hum Mol Genet. 1996;5(Spec No):1515–1519. doi: 10.1093/hmg/5.supplement_1.1515. [DOI] [PubMed] [Google Scholar]
  52. Suzuki H., Freije D., Nusskern D. R., Okami K., Cairns P., Sidransky D., Isaacs W. B., Bova G. S. Interfocal heterogeneity of PTEN/MMAC1 gene alterations in multiple metastatic prostate cancer tissues. Cancer Res. 1998 Jan 15;58(2):204–209. [PubMed] [Google Scholar]
  53. Tashiro H., Blazes M. S., Wu R., Cho K. R., Bose S., Wang S. I., Li J., Parsons R., Ellenson L. H. Mutations in PTEN are frequent in endometrial carcinoma but rare in other common gynecological malignancies. Cancer Res. 1997 Sep 15;57(18):3935–3940. [PubMed] [Google Scholar]
  54. Trybus T. M., Burgess A. C., Wojno K. J., Glover T. W., Macoska J. A. Distinct areas of allelic loss on chromosomal regions 10p and 10q in human prostate cancer. Cancer Res. 1996 May 15;56(10):2263–2267. [PubMed] [Google Scholar]
  55. Tsou H. C., Teng D. H., Ping X. L., Brancolini V., Davis T., Hu R., Xie X. X., Gruener A. C., Schrager C. A., Christiano A. M. The role of MMAC1 mutations in early-onset breast cancer: causative in association with Cowden syndrome and excluded in BRCA1-negative cases. Am J Hum Genet. 1997 Nov;61(5):1036–1043. doi: 10.1086/301607. [DOI] [PMC free article] [PubMed] [Google Scholar]
  56. Wang S. I., Puc J., Li J., Bruce J. N., Cairns P., Sidransky D., Parsons R. Somatic mutations of PTEN in glioblastoma multiforme. Cancer Res. 1997 Oct 1;57(19):4183–4186. [PubMed] [Google Scholar]
  57. Zedenius J., Wallin G., Svensson A., Bovèe J., Hög A., Bäckdahl M., Larsson C. Deletions of the long arm of chromosome 10 in progression of follicular thyroid tumors. Hum Genet. 1996 Mar;97(3):299–303. doi: 10.1007/BF02185758. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES